SoftBank Group Corp. Raises $350M Series E Funding

ShareLab（シェアラボ）

ShareLabは日本の業務用3Dプリンタ―およびAM（アディティブ・マニュファクチャリング）に関するあらゆる情報が集まるポータルサイトです。 業務用プリンタ―の価格・造形方式など基礎知識の解説から、樹脂・金属3Dプリンタ―の検索・比較、業界のニュースやイベント情報など業務用プリンタ―の導入検討に役立つ情報を満載に揃え、3Dプリンタ―の活用推進を通して、日本の製造業の発展に寄与します。

KUMONOS Corporation

Shift from "Surveying for construction" to "Surveying for preservation" I have 30 years of experience in construction surveying. In 1995, this company was established to assist in the recovery from The Great Hanshin-Awaji Earthquake. Thereafter, the number of incidents involving existing infrastructure has increased all over the world. Therefore, we have decided to focus most of our efforts on the maintenance and management of infrastructure. For this purpose, we have developed breakthrough monitoring technologies under the slogan of “Challenging to measure things that could not be measured”. I believe our advanced technology solves most of our customer’s problems and helps to preserve safety and security. President and CEO Kazuhide NAKANIWA

Raptor AI Co., Ltd.

事業内容 : End-to-end planning, development, operations, recruitment, and marketing to scale Japanese businesses for overseas customers in 12 weeks through a network of AI agents and global talent.

Woven by Toyota

Woven by Toyota exists to accelerate Toyota’s once-in-a-century transformation from a car company into a mobility company. Rooted in a legacy of reinvention, we carry forward a singular founding principle: to innovate for the benefit of others. Today, we are driving this transformation from two vantage points: redefining how vehicles are built, experienced, and connected to the world to realize a true software-defined vehicle, and reimagining how people, goods, information, and energy move and interact in society to empower individuals from all walks of life. Through these two lenses, we combine bold innovation with real-world execution, bridging the gap between present and future to help Toyota evolve its business and its role in society.

NovAccel Inc.

NovAccel is dedicated to leveraging its proprietary superconducting accelerator technology to manufacture and ensure the stable supply of medical radioisotopes (medical RIs), including Actinium-225, a key material indispensable for Targeted Alpha Therapy, an emerging next-generation cancer treatment.